nalavala

Nov

2024

GLP-1s: A Game Changer. But for Whom?

All Posts, Analysis, Industriesindustry, medicine, nalavala, ozempic

PeopleImages via iStockPhoto What are GLP-1s? The emergence of GLP-1 drugs as effective treatments for obesity has dominated the recent news. Top headlines from Bloomberg, CNBC, The New York Times, People, and numerous other publications illustrate how this product has quickly become a mainstream part of our culture. GLP-1, or glucagon-like peptide-1, is a peptide hormone antagonist that blocks glucagon secretion to prevent excess glucose from entering the bloodstream. Initially developed over 15 years ago for lowering blood sugar for Type 2 diabetics, GLP-1 drugs are now also clinically proven to reduce weight significantly. Danish pharmaceutical company Novo Nordisk led…

Oct

2024

By Ava Nalavala

The Consolidation of Online Streaming

All Posts, Analysisbusiness, competition, industry, nalavala, streaming

mphillips007 via iStockPhoto The way we watch TV and movies is changing. Before the 1980s, people often relied on broadcast TV for their shows and movies. This free, ad-supported television broadcasted to homes and typically included three-to-four national and two-to-three local channels. Next, cable was invented, and for a monthly subscription, users could access hundreds of channels and additional content for a paid subscription. The Shift to Streaming As recently as 2016, almost 100 million homes had cable TV. Then, streaming emerged, significantly changing how we consume TV and movies. When streaming started to dominate, the first main platform was…